急性早幼粒细胞白血病患者合并弥散性血管内凝血的影响因素及列线图模型构建
杨柳， 梁晶晶， 董春霞， 康建民， 郭丽萍， 赵蛟宇… - 临床血液学 …, 2023 - lcxy.whuhzzs.com
目的探讨急性早幼粒细胞白血病(APL) 合并弥散性血管内凝血(DIC) 的影响因素, 建立初诊APL
患者发生DIC 风险的预测模型, 为临床诊治提供参考. 方法回顾性分析单中心179 例初诊APL …
患者发生DIC 风险的预测模型, 为临床诊治提供参考. 方法回顾性分析单中心179 例初诊APL …
[HTML][HTML] 20 (S)-ginsenoside Rh2 ameliorates ATRA resistance in APL by modulating lactylation-driven METTL3
S Cheng, L Chen, J Ying, Y Wang, W Jiang… - Journal of Ginseng …, 2024 - Elsevier
Abstract Background 20 (S)-ginsenoside Rh2 (GRh2), an effective natural histone
deacetylase inhibitor, can inhibit acute myeloid leukemia (AML) cell proliferation. Lactate …
deacetylase inhibitor, can inhibit acute myeloid leukemia (AML) cell proliferation. Lactate …
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen …
S Kungwankiattichai, W Owattanapanich… - …, 2023 - Taylor & Francis
Introduction Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid
leukemia (AML) with a unique clinical presentation and prognosis. This study aimed to …
leukemia (AML) with a unique clinical presentation and prognosis. This study aimed to …
Analysis of early and treatment related deaths among children and adolescents with acute myeloid leukemia in Poland: 2005–2023
K Pawińska-Wąsikowska, M Czogała… - Frontiers in …, 2024 - frontiersin.org
Background A personalised approach to the treatment of acute myeloid leukemia (AML) in
children and adolescents, as well as the development of supportive therapies, has …
children and adolescents, as well as the development of supportive therapies, has …
[HTML][HTML] Cerebral Infarction as an Initial Manifestation in Acute Promyelocytic Leukemia and Deterioration After All-Trans Retinoic Acid Treatment
D Suzuki, K Kikuchi, K Sugasawa, S Saito, Y Suzuki - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
There are neither predictive tests nor preventive strategies/treatments for acute
promyelocytic leukemia (APL)-associated bleeding/thrombosis incidence. We encountered …
promyelocytic leukemia (APL)-associated bleeding/thrombosis incidence. We encountered …
[PDF][PDF] Comparison of the Effectiveness of Risk Models Used in Acute Promyelocytic Leukemia.
V Gursoy, FC HUNUTLU, IE PINAR… - … : International Journal of …, 2024 - uhod.org
Newly diagnosed acute promyelocytic leukemia (APL) patients were evaluated, and the
effectiveness of the Sanz risk model was compared with other risk models developed for …
effectiveness of the Sanz risk model was compared with other risk models developed for …
Analysis of influencing factors and establish of nomogram model of disseminated intravascular coagulation in patients with acute promyelocytic leukemia
Y Liu, L Jingjing, D Chunxia, K Jianmin… - J Clin …, 2023 - lcxyen.whuhzzs.com
To investigate the clinical features and risk factors of acute promyelocytic leukemia (APL)
complicated with disseminated intravascular coagulation (DIC), and to establish a predictive …
complicated with disseminated intravascular coagulation (DIC), and to establish a predictive …